Anil Matai reflects on 2024 as a pivotal year for India’s pharma sector
OPPI DG highlights government initiatives and industry efforts shaping a patient-centric, innovation-driven future
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
OPPI
BCG-OPPI report: Winning in the Indian healthcare market to unlock disruptive growth
The report provides perspectives on the Indian market, key trends that are shaping its future and the role global pharma companies…
EY Parthenon – OPPI report claims India’s pharma sector set for rapid growth
The report titled ‘Viksit Bharat@2047: Transforming India from pharmacy of the world to pharma powerhouse for the world’ states…
Upskilling and reskilling: Key to driving innovation in India’s pharma sector
A skilled workforce is critical to addressing the complexities of modern drug development and personalised medicine.
Making sustainability sustainable
Driven by stringent regulations, rising investor expectations, consumer demand, and operational considerations, Viveka…
Cannes Lions 2024 showcase highlights key trends shaping future pharma marketing
The showcase hosted by The Work from LIONS, in collaboration with Medulla Communications, analysed the most impactful campaigns…
DCGI waives off local trials for drugs approved in well-regulated markets
The countries on the list include the US, UK, Japan, Australia, Canada and the EU
ENTOD Pharmaceuticals appoints Prof Vivek Padgaonkar as non-executive independent director
Former OPPI Director joins ENTOD’s board, bringing expertise in pharma policy and innovation
Union Budget 2024-25 reflects a forward-looking and inclusive approach
Anil Matai, Director General, OPPI expressed that while positive strides were taken in the Union Budget 2024-25, the pharma sector…
OPPI urges government to boost R&D and innovation in pharma sector ahead of Union Budget
Anil Matai, Director General of OPPI, highlights key recommendations for enhancing pharmaceutical development in India